Total Payments
$43,860
2024 Payments
$1,477
Companies
46
Transactions
669
Medicare Patients
16,377
Medicare Billing
$2.5M
Payment Breakdown by Category
Other$26,000 (59.3%)
Food & Beverage$12,324 (28.1%)
Travel$5,368 (12.2%)
Education$168.23 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $14,000 | 3 | 31.9% |
| Food and Beverage | $12,324 | 639 | 28.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,000 | 4 | 27.4% |
| Travel and Lodging | $5,368 | 13 | 12.2% |
| Education | $168.23 | 10 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $14,224 | 51 | $0 (2024) |
| CARDIVA MEDICAL, INC. | $14,097 | 7 | $0 (2024) |
| Philips Electronics North America Corporation | $3,882 | 8 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $1,368 | 113 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,129 | 62 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,115 | 12 | $0 (2020) |
| Terumo Medical Corporation | $988.38 | 10 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $930.90 | 61 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $865.17 | 52 | $0 (2024) |
| PFIZER INC. | $771.03 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,477 | 86 | Boehringer Ingelheim Pharmaceuticals, Inc. ($278.68) |
| 2023 | $1,593 | 87 | Boehringer Ingelheim Pharmaceuticals, Inc. ($201.36) |
| 2022 | $1,503 | 84 | Novartis Pharmaceuticals Corporation ($266.57) |
| 2021 | $11,292 | 124 | BOSTON SCIENTIFIC CORPORATION ($9,483) |
| 2020 | $440.48 | 33 | Janssen Pharmaceuticals, Inc ($184.99) |
| 2019 | $10,172 | 152 | Boston Scientific Corporation ($4,490) |
| 2018 | $7,051 | 88 | CARDIVA MEDICAL, INC. ($3,000) |
| 2017 | $10,332 | 15 | CARDIVA MEDICAL, INC. ($10,000) |
All Payment Transactions
669 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Medtronic, Inc. | HAWKONE (Device) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Directional Atherectomy Devices | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.40 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | BIOTRONIK INC. | Passeo-18 (Device), Pulsar-18 T3 | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: Coronary | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE 6/7F VCS (Device) | Food and Beverage | In-kind items and services | $46.29 | General |
| Category: DEVICES | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Medtronic, Inc. | HAWKONE (Device) | Food and Beverage | In-kind items and services | $39.89 | General |
| Category: Directional Atherectomy Devices | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: EndoVenous Therapies | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.98 | General |
| Category: Cardiovascular | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: Medical Device | ||||||
| 09/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 4,215 | 7,199 | $2.2M | $636,864 |
| 2022 | 42 | 3,751 | 5,415 | $1.5M | $484,106 |
| 2021 | 39 | 4,404 | 6,653 | $1.9M | $636,180 |
| 2020 | 36 | 4,007 | 6,063 | $2.5M | $734,117 |
Total Patients
16,377
Total Services
25,330
Medicare Billing
$2.5M
Procedure Codes
173
All Medicare Procedures & Services
173 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 697 | 1,446 | $289,200 | $145,299 | 50.2% |
| 37225 | Removal of plaque in arteries of leg | Office | 2023 | 13 | 18 | $624,600 | $124,914 | 20.0% |
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2023 | 21 | 38 | $230,500 | $56,407 | 24.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 152 | 749 | $74,900 | $29,726 | 39.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 162 | 162 | $54,672 | $29,217 | 53.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 162 | 292 | $61,320 | $29,034 | 47.3% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Office | 2023 | 30 | 35 | $152,950 | $27,853 | 18.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 154 | 167 | $45,154 | $23,872 | 52.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 152 | 153 | $79,560 | $22,891 | 28.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 125 | 544 | $81,600 | $22,186 | 27.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 131 | 567 | $68,040 | $18,470 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 106 | 108 | $36,753 | $15,602 | 42.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 198 | 198 | $95,040 | $10,930 | 11.5% |
| 37253 | Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | Office | 2023 | 16 | 57 | $38,760 | $8,316 | 21.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 39 | 42 | $30,240 | $8,134 | 26.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 13 | 15 | $22,500 | $7,846 | 34.9% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 57 | 77 | $25,025 | $7,315 | 29.2% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 78 | 79 | $35,550 | $7,041 | 19.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 28 | 28 | $16,800 | $4,043 | 24.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 290 | 404 | $8,080 | $3,394 | 42.0% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 68 | 78 | $9,360 | $3,001 | 32.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 16 | $6,672 | $2,888 | 43.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 216 | 238 | $14,280 | $2,811 | 19.7% |
| 75625 | Review by radiologist of abdominal aorta image | Office | 2023 | 22 | 23 | $12,650 | $2,476 | 19.6% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 17 | 17 | $7,769 | $2,299 | 29.6% |
About Dr. Chadi Nouneh, M.D
Dr. Chadi Nouneh, M.D is a Cardiovascular Disease healthcare provider based in Evergreen Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922100403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chadi Nouneh, M.D has received a total of $43,860 in payments from pharmaceutical and medical device companies, with $1,477 received in 2024. These payments were reported across 669 transactions from 46 companies. The most common payment nature is "Honoraria" ($14,000).
As a Medicare-enrolled provider, Nouneh has provided services to 16,377 Medicare beneficiaries, totaling 25,330 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 173 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Evergreen Park, IL
- Active Since 09/03/2006
- Last Updated 12/20/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1922100403
Products in Payments
- WATCHMAN (Device) $14,058
- Vascular Closure Device (Device) $14,022
- IGT D Peripheral (Device) $2,000
- XARELTO (Drug) $1,368
- Image Guided Therapy Devices _ Coronary (Device) $1,111
- ClosureFast (Device) $1,055
- ELIQUIS (Drug) $1,043
- Navicross (Device) $868.05
- ENTRESTO (Drug) $849.15
- JARDIANCE (Drug) $731.86
- IVUS Systems (Device) $713.26
- BRILINTA (Drug) $645.68
- Repatha (Biological) $348.75
- LifeVest (Device) $337.58
- FARXIGA (Drug) $315.98
- Corlanor (Drug) $293.30
- OPSUMIT (Drug) $251.46
- CAMZYOS (Drug) $246.03
- Peripheral Orbital Atherectomy System (Device) $193.90
- Ozempic (Drug) $183.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Evergreen Park
Dr. William Spear, M.d, M.D
Cardiovascular Disease — Payments: $160,821
Cardiovascular Disease $160,821
Joaquim Spadoni Barboza, M.d, M.D
Cardiovascular Disease — Payments: $41,009
Cardiovascular Disease $41,009
Ibrahim Kassas, M.d, M.D
Cardiovascular Disease — Payments: $16,564
Cardiovascular Disease $16,564
Dr. Hussam Watti, Md, MD
Cardiovascular Disease — Payments: $5,525
Cardiovascular Disease $5,525
Dr. Ali Zaidi, Md, MD
Cardiovascular Disease — Payments: $3,793
Cardiovascular Disease $3,793
Dr. Thomas Bump, M.d, M.D
Cardiovascular Disease — Payments: $2,274
Cardiovascular Disease $2,274